Lots of factors affect a person’s risk of getting Alzheimer’s disease, the number one cause of dementia. It’s a complex mix of lifestyle, health and age, but our genetic makeup plays a particularly important role in determining whether we will get Alzheimer’s.
We bring you highlights from our 2022 Clinical Conference, exploring how innovations in dementia research can be integrated into everyday clinical practice.
Researchers at University College London (UCL) are studying a unique group of volunteers to find out how lifelong factors affect brain health
I joined Alzheimer’s Research UK in September 2020, in the midst of COVID restrictions, a burgeoning remote working culture, and a growing trend for virtual meetings and events. Last year I remotely joined the largest annual meeting of dementia researchers, the Alzheimer’s Association International Conference (AAIC), by way of their impressive virtual platform. I was…
In a world where knowledge is power and data saves lives, the paucity of data for dementia in the UK is a longstanding problem. Isolde Radford explains why we need more data for dementia
Spending a day with scientists and research volunteers at the Oxford Brain Health Clinic, what does the future hold.
Introducing our new Director of Alzheimer’s Research UK Drug Discovery Alliance Business Development
Prof John Davis has been appointed as the Director of Business Development at the Alzheimer’s Research UK Drug Discovery Alliance (DDA).
Scientific breakthroughs are on the horizon but there are big challenges to overcome if people with dementia are to receive new treatments when they become available.
Head impacts and concussion in sport is increasingly being linked to the development of later life brain problems. What progress is being made in research?